Who We Are
Investor RelationsNews

Indegene Exceeds Co-promotion forecasts for 3 Ophthalmology Brands ​

The Customer

A global pharmaceutical giant developing anti-inflammatory products. The client was looking for a partner to grow its market share and revenue for 3 pain relief products.


  • Stabilize market share for all 3 brands​

    Drive rapid top-line revenue growth by augmenting field force efforts​

The Solution

Executed integrated omnichannel campaigns through a marketing automation suite

Built customized HCP journeys and channel mix leveraging Indegene’s Next HCP Journey Optimization

Deployed emails, brand microsites, social media outreach, and live meeting environments, and fully trained VSLs and MLSs to proactively engage and train HCPs

Indegene gain-share model extracted maximum potential across 2 years. Year 1 focused on driving awareness and education and Year 2 focused on driving higher engagements leading to Rx


Omnichannel campaigns generated $16 million incremental sales in Year 1. The success of the campaign in the first year compelled the client to realign the existing sales force that led to driving $29 million incremental sales in Year 2

Engaged a total of 15,900 new HCPs over 2 years, and secured 56,419 new prescriptions through 10,331 new HCPs

Prescriptions grew by 2.3 and 1.9 times weekly in the first and second years, respectively


Rx growth in 2 years

$45 million

Incremental sales


New HCPs engaged